Cystic Fibrosis Trust responds to latest NICE update

David Ramsden, Chief Executive of Cystic Fibrosis Trust said: "The latest update from NICE confirms that no one will lose their current access to the modulator treatments and indicates that commercial negotiations between NHS England and Vertex are the likely next step. We are expecting another update at the end of January and are hopeful that all parties will now work swiftly to end the uncertainty for all of those who could benefit from these medicines in the future."